ISHARES TR - U.S. PHARMA ETF (IHE)

CUSIP: 464288836

Q1 2023 13F Holders as of 31 Mar 2023

Share change
-23,521
Put/Call ratio
0%
SEC-reported price per share
$175.28
Number of holders
127
Value change
-$4,630,135
Number of buys
48
Show 1 more signal
Number of sells
42

Security key

464288836

Report period

Q1 2023

Institutions

127

Top holders

10

Ownership snapshot

Top reported holders of IHE - ISHARES TR - U.S. PHARMA ETF (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
127
Shares
734,313
Rows available
127
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 holders
127
Q1 2023 holders
127
Holder diff
0
Investor Q4 2022 Shares Q1 2023 Shares Share Diff Share Chg % Q4 2022 value Q1 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .